Zhejiang Huahai Pharmaceutical Co., Ltd is a leading manufacturer based in China, specialising in active pharmaceutical ingredients (APIs), intermediates, and formulated dosage forms. The company is dedicated to the healthcare industry, striving to provide high-quality medical and health products to patients worldwide. Established in 1989, Zhejiang Huahai Pharmaceutical has achieved numerous certifications, including ISO 14001 and GMP approvals. The plant has been inspected and approved by the TGA, the US FDA, and the EU Authority. Their product series includes ACE inhibitors, angiotensin receptor antagonists, anti-depressants, and anti-HIV medications. The company has also secured COS certification for 12 products, with an additional 11 products currently undergoing the COS application process. Furthermore, they have filed Drug Master Files (DMF) for 30 products with the US FDA.

Services include:
- Manufacturing of Active Pharmaceutical Ingredients (APIs)
- Production of pharmaceutical intermediates
- Development of formulated dosage forms
- Compliance with GMP and ISO 14001 standards
- COS certification processing
- DMF filing support for regulatory approvals

Zhejiang Huahai Pharmaceutical Co., Ltd continues to enhance its portfolio of high-quality pharmaceutical products while ensuring adherence to stringent international standards. For more information, please visit huahaipharm.com.